- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05653089
Positioning in Wheelchair Bound Patients (AAPO'G)
Evaluation of Actions to Improve Positioning in Wheelchaire Bound Patients at Risk of Slipping : Pilot Study
The choice of the most suitable chair as well as the improvement of the patient's positioning on this wheelchair is important to limit the discomfort, to prevent the risks of bedsores, the pains related to prolonged sitting and finally to support the interaction of the patient with its environment. The goal of this prospective, longitudinale, monocentric study is to evaluate the impact of standardized positioning in wheelchair-bound patients at risk of slipping.
The main questions on the positioning actions are:
- their actions impact of positioning actions on shear forces
- their impact on sliding in the chair
- their impact on the feeling of discomfort in the chair
- their impact on the caregivers' feelings about the patient's difficulties (eating, transfers, sliding)
Participation in this study will involve an increase in the number of transfers required for shear sheet placement and removal, as well as the time required for ischial measurement and the time to complete the (Tool for Assessing Wheelchair disComfort) TAWC questionnaire.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Julien PAGER
- Email: julien.pager@fondation-hopale.org
Study Contact Backup
- Name: Marine Deseur
- Phone Number: +33362882780
- Email: marine.deseur@fondation-hopale.org
Study Locations
-
-
Hauts DE France
-
Berck, Hauts DE France, France, 62608
- Recruiting
- Julien PAGER
-
Contact:
- Julien PAGER
- Email: julien.pager@fondation-hopale.org
-
Principal Investigator:
- Jean Gabriel PREVINAIRE, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient hospitalized for a minimum of 9 days (minimum 48-hour reflection period after information)
- Patient aged between 18 and 80 years,
- Patient with a sitting time in a wheelchair > or equal to 1 hour,
- Patient with a neurological condition : multiple sclerosis, stroke, spinal cord injury, Parkinson disease, neurodegenerative diseases...
- Patient informed of the study and having given his written consent,
Non inclusion Criteria:
- Cognitive disorders that do not allow the understanding of instructions
- Patient with a pressure sore
- Pregnant or breastfeeding woman
- Patient under legal protection
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: All patients meeting the study eligibility criteria
|
After a personalized analysis of the patient and his needs, the occupational therapists define the equipment necessary for the good positioning of the patient:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evolution of shear measurement with the Shear® sensor
Time Frame: Day 0 therefore before the implementation of the positioning actions then at Day 1 and Day 7
|
Shear will be measured over a period of one hour (shear evolution over one hour), during which the patient will follow a standardized activity program.
|
Day 0 therefore before the implementation of the positioning actions then at Day 1 and Day 7
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of the sliding distance
Time Frame: Day 0 therefore before the implementation of the positioning actions then at Day 1 and Day 7
|
The sliding distance is measured by the position of the ischiums.
It is the difference between the position measured before and after 1 hour of standardized activities.
|
Day 0 therefore before the implementation of the positioning actions then at Day 1 and Day 7
|
|
Evolution of the score on the TAWC scale
Time Frame: Day 0 therefore before the implementation of the positioning actions then at Day 7
|
The TAWC (Tool for Assessing Wheelchair discomfort) scale assesses 2 discomfort scores:
|
Day 0 therefore before the implementation of the positioning actions then at Day 7
|
|
Evolution of the caregiver questionnaire score (Likert scale)
Time Frame: Day 0 therefore before the implementation of the positioning actions then at Day 7
|
Day 0 therefore before the implementation of the positioning actions then at Day 7
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jean Gabriel PREVINAIRE, MD, Fondation Hopale
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HOP-RIPH2-21-05
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurological Disease
-
University of LeedsThe Royal College of Surgeons of EnglandCompletedSurgery | Surgery--Complications | Outcome, Fatal | Neurological Disorder | Morality | Neurological Morbidity | Neurological Complication | Comorbidities and Coexisting Conditions | Neurological Diseases or Conditions | Neurological Procedural Complication
-
Universidad Autonoma de San Luis PotosíUnknownNeurological DiseaseMexico
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingNeurological Diseases | Auto Immune Disease
-
University of North Carolina, Chapel HillCompleted
-
IRCCS Eugenio MedeaCompletedNeurological Diseases or ConditionsItaly
-
Neurogen Brain and Spine InstituteWithdrawn
-
Beth Israel Deaconess Medical CenterDartmouth CollegeCompletedNeuromuscular Disease Patients | Central Neurological Disease PatientsUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedParaneoplastic Neurological SyndromesFrance
-
Centre Hospitalier Universitaire de la RéunionRecruitingNeurological ComplicationRéunion
-
Shanghai Jiao Tong University School of MedicineCompletedNeurological ImpairmentsChina
Clinical Trials on Choice and adjustment of the wheelchair according to the patient's needs
-
iOMEDICO AGRecruitingCarcinoma | Ovarian Cancer | Endometrial Neoplasms | Endometrial Cancer | Ovary Neoplasm | Neoplasm, Ovarian | Carcinoma, OvarianGermany
-
iOMEDICO AGActive, not recruiting
-
iOMEDICO AGRecruiting
-
Centre Hospitalier Universitaire de Saint EtienneCompletedPregnancy | Induced; BirthFrance
-
Pôle Saint HélierNot yet recruitingCaregiver | Person With a DisabilityFrance
-
Gustave Roussy, Cancer Campus, Grand ParisCompleted
-
Second Affiliated Hospital of Wenzhou Medical UniversityRecruitingAcute Respiratory Distress SyndromeChina
-
Central Hospital, Nancy, FranceRecruiting
-
Peking Union Medical College HospitalUnknownHPV-Related Squamous Cell CarcinomaChina
-
Assistance Publique Hopitaux De MarseilleUnknownInfective Endocarditis (IE)France